UNSPSC 51101696: Aminosalicylate sodium or sodium aminosalicylate

This classification denotes an antitubercular agent with the molecular formula C7H6NO3.Na.2H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier S38B9W6AXW, chemically known as 4-amino,2-hydroxy-benzoic acid but more generally known as aminosalicylate sodium, which bears U.S. National Institutes of Health Compound Identifier 4649. European Medicines Agency schedules Aminosalicylate sodium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB12861MIG.

UNSPSC 51101696 Aminosalicylate sodium or sodium aminosalicylate is a Commodity code with minimal recent state and local procurement activity that aligns with its nominal scope. The two recent opportunities tagged under this code involve pharmaceutical products—Doxycycline Hyclate and Ciprofloxacin Hydrochloride tablets through an Illinois Department of Public Health piggyback award, and Naloxone and drug deactivation systems through a Seminole County, Florida procurement—neither of which is aminosalicylate sodium. State and local health departments and counties appear to use this code when purchasing pharmaceuticals and medical supplies through competitive bidding and cooperative purchasing vehicles, but the recent record shows no active solicitations or awards for aminosalicylate sodium itself.

The code sees activity across at least two states—Illinois and Florida—in the health and human services procurement space. The Illinois Department of Public Health awarded a $2,999,999.11 pharmaceutical warehouse piggyback contract to Chartwell Rx LLC on August 28, 2026, through the MMCAP Infuse consortium with a 12-month initial term and renewal options for years 2 and 3; Seminole County issued an IFB for Naloxone and drug deactivation systems with a due date of July 26, 2023, requiring 1,900 units of Naloxone and 800 deactivation systems annually with quarterly deliveries. No open solicitations for aminosalicylate sodium are currently posted. Vendors pursuing activity under this code should monitor health department and county procurement channels directly and verify that the specific pharmaceutical product is relevant before committing bid resources, as recent tagging patterns under this code do not reliably reflect aminosalicylate sodium demand.